Guess which ASX All Ords share just rocketed 40%

Shares in investigative analytics software provider are moving like a bat out of hell.

| More on:
Man pointing at a blue rising share price graph.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • Shares in this investigative analytics company are up 40% to $1.15 today
  • The sensational reception comes amid management's rosy expectations for the company's FY24 full-year results
  • Statutory EBITDA is forecast to increase between 164% to 189% compared to the prior year

One ASX All Ords share is putting the rest of the S&P/ASX All Ordinaries Index (ASX: XAO) to shame today.

Shares in investigative analytics software provider Nuix Ltd (ASX: NXL) are moving like a bat out of hell following the release of the company's FY23 preliminary results update. As we head into the afternoon, the share price is currently trading at $1.15, up 40.2% from yesterday.

Let's take a closer look at what is getting investors excited.

Promising signs for growth

Earlier this morning, Nuix shares were up as much as 51.2%, marking the biggest jump in share price in more than five months. While the enthusiasm has calmed as the day has gone on, the unaudited financials for FY2023 are no less delighting shareholders.

Following a succession of disappointing results since its listing in 2020, the software provider is giving its first glimpse of a change in trajectory.

In its update, the ASX All Ords constituent revealed it expects substantial increases across several metrics for the full year, including:

  • Annualised contract value (ACV) between $184 million and $186 million — up 14% to 15%
  • Statutory revenue between $181 million and $183 million — up 19% to 20%
  • Underlying EBITDA between $44 million to $47 million — up 51% to 61%
  • Statutory EBITDA between $32 million to $35 million — up 164% to 189%

It should be noted that the underlying figure excludes non-operational legal costs and costs related to its acquisition of Topos.

According to the release, the strong performance was aided by several key contracts being executed in June. Additionally, currency fluctuations assisted Nuix's ACV and statutory revenue by 3% to 4%.

Shareholders might also be looking favourably at the reduction in legal costs year-on-year. While these costs grew from the first half to the second half — as previously expected — the amount fell from $14 million to $8 million in FY22 versus FY23.

What's ahead for this ASX All Ords share?

It's been a wild ride for Nuix shareholders in 2023. In the first month and a half of the year, the company's shares skyrocketed 138%, followed by a bumpy decline (charted below) — until today.

Today's rally takes the Nuix share price to a year-to-date gain of 75%. However, the figures presented today are preliminary. The final full-year numbers will be shared with investors on 18 August.

Those that have stuck with this ASX All Ords share should then get a glimpse at where management's expectations lay for FY24.

Motley Fool contributor Mitchell Lawler has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Latin Resources, Newmont, Nick Scali, and ResMed shares are surging today

These ASX shares are ending the week strongly. But why?

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

Let's also take a look at what the various ASX sectors were doing this Wednesday.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Argosy Minerals, Immutep, Pointsbet, and Regis Resources shares are racing higher

These shares are having a strong session on Wednesday. But why?

Read more »

Businessman smiles with arms outstretched after receiving good news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another strong showing from the share market today.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

These shares are having a strong session. But why?

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Smiling man working on his laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to the races for ASX shares today, in a confident start to the week.

Read more »

rising gold share price represented by a green arrow on piles of gold block
Share Gainers

Here are the top 10 ASX 200 shares today

It was a horrible way to end the trading week today for ASX investors.

Read more »